|
Name |
Accession |
Description |
Interval |
E-value |
| PRK13037 |
PRK13037 |
superantigen-like protein SSL1; Reviewed; |
1-226 |
3.69e-150 |
|
superantigen-like protein SSL1; Reviewed;
Pssm-ID: 106074 Cd Length: 226 Bit Score: 416.68 E-value: 3.69e-150
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446591657 1 MKFKAIAKASLALGMLATGVITSNVQSVQAKAEVKQQSEADLKLYYSGPSFEYKKVTGYGFVEGKDRFIDFIYNGQYNKI 80
Cdd:PRK13037 1 MKFKAIAKASLALGMLATGVITSNVQSVQAKTEVKQQSESELKHYYNKPVLERKNVTGYKYTEKGKDYIDVIVDNQYSQI 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446591657 81 SLVGSDKDKYNEEVNPDIDVFVVREGNGRQADNHSIGGVTKTNRGVYYDYIHTPILEIKKGKEEPQSSLYQIYKEDISLK 160
Cdd:PRK13037 81 SLVGSDKDKFKDGDNSNIDVFILREGDSRQATNYSIGGVTKTNSQPYIDYIHTPILEIKKGKEEPQSSLYQIYKEDISLK 160
|
170 180 190 200 210 220
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 446591657 161 ELDYRLRERAIKHHGLYSKGLKQGQITITMNDGTTHTIDLSQKLEKERMGQSVDGKQIQKILVEMK 226
Cdd:PRK13037 161 ELDYRLRERAIKQHGLYSNGLKQGQITITMKDGKSHTIDLSQKLEKERMGESIDGRQIQKILVEMK 226
|
|
| SSL_OB |
pfam09199 |
Staphylococcal superantigen-like OB-fold domain; This OB-fold domain folds into a ... |
41-123 |
3.14e-24 |
|
Staphylococcal superantigen-like OB-fold domain; This OB-fold domain folds into a five-stranded beta-barrel. Members of this family are found in various staphylococcal toxins described as staphylococcal superantigen-like (SSL) proteins that are related to the staphylococcal enterotoxins (SEs) or superantigens. These SSL proteins of which 11 have so far been characterized have a typical SE tertiary structure consisting of a distinct oligonucleotide/oligosaccharide binding (OB-fold), this domain, linked to a beta-grasp domain, family Stap_Strp_tox_C, pfam02876. SSLs do not bind to T-cell receptors or major histocompatibility complex class II molecules and do not stimulate T cells. SSLs target components of innate immunity, such as complement, Fc receptors, and myeloid cells 2,3,4,5,6,7,8]. SSL protein 7 (SSL7) is the best characterized of the SSLs and binds complement factor C5 and IgA with high affinity and inhibits the end stage of complement activation and IgA binding to FcalphaR.
Pssm-ID: 401224 [Multi-domain] Cd Length: 84 Bit Score: 91.60 E-value: 3.14e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446591657 41 DLKLYYSGPSFEYKKVTGYGFVEGKDRFIDFIYNGQYNKISLVGSDKDKYNEEVNPDIDVFVVREGNGRQADNHSIGGVT 120
Cdd:pfam09199 2 DLKAYYSKPSFELKNVSGYKEKKTGKNFLNFTPNNQKYQVALLGKDKEKYKEGEHDNLDVFVVRELEDRNGRKYSVGGVT 81
|
...
gi 446591657 121 KTN 123
Cdd:pfam09199 82 KKN 84
|
|
|
|
Name |
Accession |
Description |
Interval |
E-value |
| PRK13037 |
PRK13037 |
superantigen-like protein SSL1; Reviewed; |
1-226 |
3.69e-150 |
|
superantigen-like protein SSL1; Reviewed;
Pssm-ID: 106074 Cd Length: 226 Bit Score: 416.68 E-value: 3.69e-150
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446591657 1 MKFKAIAKASLALGMLATGVITSNVQSVQAKAEVKQQSEADLKLYYSGPSFEYKKVTGYGFVEGKDRFIDFIYNGQYNKI 80
Cdd:PRK13037 1 MKFKAIAKASLALGMLATGVITSNVQSVQAKTEVKQQSESELKHYYNKPVLERKNVTGYKYTEKGKDYIDVIVDNQYSQI 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446591657 81 SLVGSDKDKYNEEVNPDIDVFVVREGNGRQADNHSIGGVTKTNRGVYYDYIHTPILEIKKGKEEPQSSLYQIYKEDISLK 160
Cdd:PRK13037 81 SLVGSDKDKFKDGDNSNIDVFILREGDSRQATNYSIGGVTKTNSQPYIDYIHTPILEIKKGKEEPQSSLYQIYKEDISLK 160
|
170 180 190 200 210 220
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 446591657 161 ELDYRLRERAIKHHGLYSKGLKQGQITITMNDGTTHTIDLSQKLEKERMGQSVDGKQIQKILVEMK 226
Cdd:PRK13037 161 ELDYRLRERAIKQHGLYSNGLKQGQITITMKDGKSHTIDLSQKLEKERMGESIDGRQIQKILVEMK 226
|
|
| PRK13036 |
PRK13036 |
superantigen-like protein SSL11; Reviewed; |
1-225 |
3.61e-61 |
|
superantigen-like protein SSL11; Reviewed;
Pssm-ID: 171852 Cd Length: 227 Bit Score: 191.31 E-value: 3.61e-61
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446591657 1 MKFKAIAKASLALGMLATGVITSNVQSVQA-KAEVKQQSEADLKLYYSGPSFEYKKVTGYGFvEGKDRFIDfiyNGQYNK 79
Cdd:PRK13036 1 MKLKNIAKASLALGILTTGMITTTAQPVKAsTLEVRSQATQDLSEYYKGRGFELTNVSGYKE-GNKVTFID---NSQLID 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446591657 80 ISLVGSDKDKYNEEVN-PDIDVFVVREGNGRQADNHSIGGVTKTNRGVYYDYIHTPILEIKKGKEE----PQSSLYQIYK 154
Cdd:PRK13036 77 VTLTGNEKLTFKDDEDvSNVDVFVVREGSDKSAITTSIGGITKTNGTQYKDTVQNVNLSISKSTGQhttsVTSEYYSINK 156
|
170 180 190 200 210 220 230
....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 446591657 155 EDISLKELDYRLRERAIKHHGLYSKGLKQGQITITMNDGTTHTIDLSQKLEKERMGQSVDGKQIQKILVEM 225
Cdd:PRK13036 157 EEISLKELDFKLRKHLIDKHDLYKTEPKDSKIRITMKNGGYYTFELNKKLQPHRMGDTIDSRNIEKIEVNL 227
|
|
| PRK13035 |
PRK13035 |
superantigen-like protein SSL5; Reviewed; |
1-226 |
5.21e-51 |
|
superantigen-like protein SSL5; Reviewed;
Pssm-ID: 171851 Cd Length: 234 Bit Score: 165.62 E-value: 5.21e-51
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446591657 1 MKFKAIAKASLALGMLATGVITSNVQSV-----QAKAEVKQQSEADLKLYYSGPSFEYKKVTGYGFVEGKDRFIDFIYNG 75
Cdd:PRK13035 1 MKMAAIAKASLALGILATGTITSLHQTVnasehEAKYENVTKDIFDLRDYYSGASKELKNVTGYRYSKGGKHYLIFDKNR 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446591657 76 QYNKISLVGSDKDKYNEEVNPDIDVFVVREGNGRQADNHSIGGVTKTNRGVYYDYIHTPILEIKKGKEEPQSS---LYQI 152
Cdd:PRK13035 81 KFTRVQIFGKDIERFKARKNPGLDIFVVKEAENRNGTVFSYGGVTKKNQDAYYDYINAPRFQIKRDEGDGIATygrVHYI 160
|
170 180 190 200 210 220 230
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 446591657 153 YKEDISLKELDYRLRERAIKHHGLYSKGLKQGQITITMNDGTTHTIDLSQKLEKERMGQSVDGKQIQKILVEMK 226
Cdd:PRK13035 161 YKEEISLKELDFKLRQYLIQNFDLYKKFPKDSKIKVIMKDGGYYTFELNKKLQTNRMSDVIDGRNIEKIEANIR 234
|
|
| PRK13346 |
PRK13346 |
superantigen-like protein SSL7; Reviewed; |
1-226 |
1.81e-45 |
|
superantigen-like protein SSL7; Reviewed;
Pssm-ID: 106304 [Multi-domain] Cd Length: 231 Bit Score: 151.31 E-value: 1.81e-45
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446591657 1 MKFKAIAKASLALGMLATGVITSNVQSVQAKAEVKQQSE----ADLKLYYSGPSFEYKKVTGYGFVEGKDRFIDFIYNGQ 76
Cdd:PRK13346 1 MKLKTLAKATLALGLLTTGVITSEGQAVQAKEKQERVQHlydiKDLHRYYSSESFEFSNISGKVENYNGSNVVRFNQENQ 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446591657 77 YNKISLVGSDKDKYNEEVNPDiDVFVVRE---GNGRQAdnhSIGGVTKTNRGVYYDYIHTPILEIKKGKEEPQSSLYQIY 153
Cdd:PRK13346 81 NHQLFLLGKDKDKYKEGLEGQ-NVFVVKElidPNGRLS---TVGGVTKKNNKSSETNTHLFVNKVYGGNLDASIDSFLIN 156
|
170 180 190 200 210 220 230
....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 446591657 154 KEDISLKELDYRLRERAIKHHGLYSKGLKQGQITITMNDGTTHTIDLSQKLEKERMGQSVDGKQIQKILVEMK 226
Cdd:PRK13346 157 KEEVSLKELDFKIRQQLVENYGLYKGTTKYGKITINLKDEKKEEIDLGDKLQFERMGDVLNSKDIQNIAVTIN 229
|
|
| PRK13042 |
PRK13042 |
superantigen-like protein SSL4; Reviewed; |
1-226 |
1.78e-42 |
|
superantigen-like protein SSL4; Reviewed;
Pssm-ID: 183854 [Multi-domain] Cd Length: 291 Bit Score: 145.16 E-value: 1.78e-42
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446591657 1 MKFKAIAKASLALGMLATGVITSNVQSVQA------KAEVKQ------QSEA---------------------------- 40
Cdd:PRK13042 1 MKITTIAKTSLALGLLTTGVITTTTQAANAttpsstKVEAPQstppstKVEApqskpnattppstkveapqqtpnattps 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446591657 41 ------------------------DLKLYYSGPSFEYKKvtGYGFVEGK---DRFIDFIYNGQYNKISLVGSDKDKYNEE 93
Cdd:PRK13042 81 stkvetpqspttkqvpteinpkfkDLRAYYTKPSLEFKN--EIGIILKKwttIRFMNVVPDYFIYKIALVGKDDKKYGEG 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446591657 94 VNPDIDVFVVREGNGRQADNHSIGGVTKTN-RGVYYDYIHTPILEIKKGKEEPQSSLYQIYKEDISLKELDYRLRERAIK 172
Cdd:PRK13042 159 VHRNVDVFVVLEENKYNLEKYSVGGITKSNsKKVDHKAGVRITKEDNKGTISHDVSEFKITKEQISLKELDFKLRKQLIE 238
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....
gi 446591657 173 HHGLYSKgLKQGQITITMNDGTTHTIDLSQKLEKERMGQSVDGKQIQKILVEMK 226
Cdd:PRK13042 239 KHNLYGN-VGSGKIVIKMKNGGKYTFELHKKLQENRMADVIDGTNIDNIEVNIK 291
|
|
| PRK13038 |
PRK13038 |
superantigen-like protein SSL10; Reviewed; |
1-226 |
1.70e-41 |
|
superantigen-like protein SSL10; Reviewed;
Pssm-ID: 171853 Cd Length: 227 Bit Score: 140.92 E-value: 1.70e-41
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446591657 1 MKFKAIAKASLALGMLATGVITSNVQSVQAKAEVKQQSEAD---LKLYYSGPSFEYKKVTGygFVEGKDRfIDFIYNGQY 77
Cdd:PRK13038 1 MKFTALAKATLALGILTTGTLTTEVHSGHAKQNQKSVNKHDkeaLYRYYTGKTMEMKNISA--LKHGKNN-LRFKFRGIK 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446591657 78 NKISLVGSDKDKYNEEVNPDIDVFVVREGNGRQADNHSIGGVTKTNRGVyyDYIHTPILEIKKGKEEP---QSSLYQIYK 154
Cdd:PRK13038 78 IQVLLPGNDKSKFQQRSYEGLDVFFVQEKRDKHDIFYTVGGVIQNNKTS--GVVSAPILNISKEKGEDafvKGYPYYIKK 155
|
170 180 190 200 210 220 230
....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 446591657 155 EDISLKELDYRLRERAIKHHGLYSKGLKQGQITITMNDGTTHTIDLSQKLEKERMGQSVDGKQIQKILVEMK 226
Cdd:PRK13038 156 EKITLKELDYKLRKHLIEKYGLYKTISKDGRVKISLKDGSFYNLDLRSKLKFKYMGEVIESKQIKDIEVNLK 227
|
|
| PRK13335 |
PRK13335 |
superantigen-like protein SSL3; Reviewed; |
29-226 |
4.42e-41 |
|
superantigen-like protein SSL3; Reviewed;
Pssm-ID: 139494 [Multi-domain] Cd Length: 356 Bit Score: 143.34 E-value: 4.42e-41
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446591657 29 QAKAEVKQQSEaDLKLYYSGPSFEYKKvtGYGFVEGK---DRFIDFIYNGQYNKISLVGSDKDKYNEEVNPDIDVFVVRE 105
Cdd:PRK13335 159 QAQTDMTPKYE-DLRAYYTKPSFEFEK--QFGFLLKPwttVRFMNVIPNRFIYKIALVGKDEKKYKDGPYDNIDVFIVLE 235
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446591657 106 GNGRQADNHSIGGVTKTNR-GVYYDYIHTPILEIKKGKEEPQSSLYQIYKEDISLKELDYRLRERAIKHHGLYSKgLKQG 184
Cdd:PRK13335 236 DNKYQLKKYSVGGITKTNSkKVDHKAELSITKKDNQGMISRDVSEYMITKEEISLKELDFKLRKQLIEKHNLYGN-MGSG 314
|
170 180 190 200
....*....|....*....|....*....|....*....|..
gi 446591657 185 QITITMNDGTTHTIDLSQKLEKERMGQSVDGKQIQKILVEMK 226
Cdd:PRK13335 315 TIVIKMKNGGKYTFELHKKLQEHRMADVIDGTNIDKIEVNIK 356
|
|
| PRK13041 |
PRK13041 |
superantigen-like protein SSL2; Reviewed; |
1-226 |
5.49e-40 |
|
superantigen-like protein SSL2; Reviewed;
Pssm-ID: 106078 Cd Length: 231 Bit Score: 137.07 E-value: 5.49e-40
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446591657 1 MKFKAIAKASLALGMLATGVITSNVQSVQA--KAEVKQQSEADLKLYYSGPSFEYKKVTGY-GFVEGKDRFIDFIYNGQY 77
Cdd:PRK13041 1 MKMKNIAKISLLLGILATGVNTTTEKPVHAekKPIVISENSKKLKAYYTQPSIEYKNVTGYiSFIQPSIKFMNIIDGNSV 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446591657 78 NKISLVGSDKDKYNEEVNPDIDVFVVREGNGRQADNHSIGGVTKTNRGVyYDYIHTP--ILEIKKGKEEPQSSLYQIYKE 155
Cdd:PRK13041 81 NNLALIGKDKQHYHTGVHRNLNIFYVNEDKRFEGAKYSIGGITSANDKA-VDLIAEArvIKADHIGEYDYDFFPFKIDKE 159
|
170 180 190 200 210 220 230
....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 446591657 156 DISLKELDYRLRERAIKHHGLYSKgLKQGQITITMNDGTTHTIDLSQKLEKERMGQSVDGKQIQKILVEMK 226
Cdd:PRK13041 160 AMSLKEIDFKLRKYLIDNYGLYGE-MSTGKITVKKKYYGKYTFELDKKLQEDRMSDVINVTDIDRIEIKVR 229
|
|
| PRK13040 |
PRK13040 |
superantigen-like protein SSL6; Reviewed; |
1-226 |
6.62e-36 |
|
superantigen-like protein SSL6; Reviewed;
Pssm-ID: 106077 Cd Length: 231 Bit Score: 126.38 E-value: 6.62e-36
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446591657 1 MKFKAIAKASLALGMLATGVITSNVQSVQAKAEVK-QQSEADLKLYYSGPSFEYKKVTGYGFVEGKDRFIDFIYNGQYNK 79
Cdd:PRK13040 1 MKLKTLAKATLVLGLLATGVITTESQTVKAAESTQgQHNYKSLKYYYSKPSIELKNLDGLYRQKVTDKGVYVWKDRKDYF 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446591657 80 ISLVGSDKDKYNEEVNPDIDVFVVREGNGRQADNHSIGGVTKTNRGVYYDYIHTPIL-EIKKGKEEPQSSLYQIYKEDIS 158
Cdd:PRK13040 81 VGLLGKDIEKYPQGEHDKQDAFLVIEEETVNGRQYSIGGLSKTNSKEFSKEVDVKVTrKIDESSEKSKDSKFKITKEEIS 160
|
170 180 190 200 210 220
....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 446591657 159 LKELDYRLRERAIKHHGLYSK-GLKQGQITITMNDGTTHTIDLSQKLEKERMGQSVDGKQIQKILVEMK 226
Cdd:PRK13040 161 LKELDFKLRKKLMEEEKLYGAvNNRKGKIVVKMEDDKFYTFELTKKLQPHRMGDTIDGTKIKEINVELE 229
|
|
| PRK13345 |
PRK13345 |
superantigen-like protein SSL9; Reviewed; |
1-225 |
2.78e-34 |
|
superantigen-like protein SSL9; Reviewed;
Pssm-ID: 106303 Cd Length: 232 Bit Score: 122.42 E-value: 2.78e-34
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446591657 1 MKFKAIAKASLALGMLATGVITSNVQSVQAKAEVKQQSEA----DLKLYYSGPSFEYKKVTgygfVEGKDRF----IDFI 72
Cdd:PRK13345 1 MKLTALAKATLALGILTTGVFTAESKAVHAKVELDETQRKyyinMLHQYYSEESFEPTNIS----VKSEDYYgsnvLNFK 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446591657 73 YNGQYNKISLVGSDKDKYNEEVNpDIDVFVVREGNGRQADNHSIGGVTKTNRGVYYDYIHTPILEIKKGKEEPQSS---L 149
Cdd:PRK13345 77 QRNKAFKVFLLGDDKNKYKEKTH-GLDVFAVPELIDIKGGIYSVGGITKKNVRSVFGFVSNPSLQVKKVDAKHGFSineL 155
|
170 180 190 200 210 220 230
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 446591657 150 YQIYKEDISLKELDYRLRERAIKHHGLYSKGLKQGQITITMNDGTTHTIDLSQKLEKERMGQSVDGKQIQKILVEM 225
Cdd:PRK13345 156 FFIQKEEVSLKELDFKIRKMLVEKYRLYKGASDKGRIVINMKDEKKYVIDLSEKLSFDRMFDVMDSKQIKNIEVNL 231
|
|
| PRK13039 |
PRK13039 |
superantigen-like protein SSL8; Reviewed; |
1-226 |
6.04e-33 |
|
superantigen-like protein SSL8; Reviewed;
Pssm-ID: 171854 Cd Length: 232 Bit Score: 119.03 E-value: 6.04e-33
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446591657 1 MKFKAIAKASLALGMLATGVITSNVQSVQAKAEVKQQSEA----DLKLYYSGPSFEYKKVTGYGFVEGKDRFIDFIYNGQ 76
Cdd:PRK13039 1 MKFTAIAKAIFVLGILTTSVMITENQSVNAKGKYEKMNRLydtnKLHQYYSGPSYELTNVSGQSQGYYDSNVLLFNQQNQ 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446591657 77 YNKISLVGSDKDKYNEEVNpDIDVFVVREGNGRQADNHSIGGVTKTNRGVYYDYIHTPILEIKKGKEEPQSS---LYQIY 153
Cdd:PRK13039 81 KFQVFLLGKDENKYKEKTH-GLDVFAVPELVDLDGRIFSVSGVTKKNVKSIFESLRTPNLLVKKIDDKDGFSideFFFIQ 159
|
170 180 190 200 210 220 230
....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 446591657 154 KEDISLKELDYRLRERAIKHHGLYSKGLKQGQITITMNDGTTHTIDLSQKLEKERMGQSVDGKQIQKILVEMK 226
Cdd:PRK13039 160 KEEVSLKELDFKIRKLLIKKYKLYEGSADKGRIVINMKDENKYEIDLSDKLDFERMADVINSEQIKNIEVNLK 232
|
|
| SSL_OB |
pfam09199 |
Staphylococcal superantigen-like OB-fold domain; This OB-fold domain folds into a ... |
41-123 |
3.14e-24 |
|
Staphylococcal superantigen-like OB-fold domain; This OB-fold domain folds into a five-stranded beta-barrel. Members of this family are found in various staphylococcal toxins described as staphylococcal superantigen-like (SSL) proteins that are related to the staphylococcal enterotoxins (SEs) or superantigens. These SSL proteins of which 11 have so far been characterized have a typical SE tertiary structure consisting of a distinct oligonucleotide/oligosaccharide binding (OB-fold), this domain, linked to a beta-grasp domain, family Stap_Strp_tox_C, pfam02876. SSLs do not bind to T-cell receptors or major histocompatibility complex class II molecules and do not stimulate T cells. SSLs target components of innate immunity, such as complement, Fc receptors, and myeloid cells 2,3,4,5,6,7,8]. SSL protein 7 (SSL7) is the best characterized of the SSLs and binds complement factor C5 and IgA with high affinity and inhibits the end stage of complement activation and IgA binding to FcalphaR.
Pssm-ID: 401224 [Multi-domain] Cd Length: 84 Bit Score: 91.60 E-value: 3.14e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446591657 41 DLKLYYSGPSFEYKKVTGYGFVEGKDRFIDFIYNGQYNKISLVGSDKDKYNEEVNPDIDVFVVREGNGRQADNHSIGGVT 120
Cdd:pfam09199 2 DLKAYYSKPSFELKNVSGYKEKKTGKNFLNFTPNNQKYQVALLGKDKEKYKEGEHDNLDVFVVRELEDRNGRKYSVGGVT 81
|
...
gi 446591657 121 KTN 123
Cdd:pfam09199 82 KKN 84
|
|
| PRK13350 |
PRK13350 |
superantigen-like protein SSL12; Reviewed; |
1-226 |
3.32e-12 |
|
superantigen-like protein SSL12; Reviewed;
Pssm-ID: 171995 [Multi-domain] Cd Length: 238 Bit Score: 63.83 E-value: 3.32e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446591657 1 MKFKAIAKASLALGMLATGVITSNVQ------SVQAKAEVKQQSEA---DLKLYYSGP--SFEYKKVTGYG----FVEGK 65
Cdd:PRK13350 1 MSKNITKNIILTTTLLLLGTVLPQNQkpvfsfYSEAKAYSIGQDETninELIKYYTQPhfSFSNKWLYQYDngniYVELK 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446591657 66 DR----FIDFIYNGQYNKISLVgsdKDKYneevnpdIDVFVVREGNGRQA----DNHSIGGVTKTNRGVYYDYihtPILE 137
Cdd:PRK13350 81 RYswsaHISLWGAESWGNINQL---KDRY-------VDVFGLKDKDTDQLwwsyRETFTGGVTPAAKPSDKTY---NLFV 147
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446591657 138 IKKGKEEPQSSLYQIY---KEDISLKELDYRLRERAIKHHGLYSKGLKQGQITITmNDGTTHTIDLSQKLEKERMGQSVD 214
Cdd:PRK13350 148 QYKDKLQTIIGAHKIYqgnKPVLTLKEIDFRAREALIKNKILYNENRNKGKLKIT-GGGNNYTIDLSKRLHSDLANVYVK 226
|
250
....*....|..
gi 446591657 215 GKQIQKILVEMK 226
Cdd:PRK13350 227 NPNKITVDVLFD 238
|
|
| PRK13043 |
PRK13043 |
superantigen-like protein SSL14; Reviewed; |
149-205 |
1.86e-07 |
|
superantigen-like protein SSL14; Reviewed;
Pssm-ID: 171855 Cd Length: 241 Bit Score: 50.09 E-value: 1.86e-07
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|....*..
gi 446591657 149 LYQIYKEDISLKELDYRLRERAIKHHGLYSKGLKQGQITITmNDGTTHTIDLSQKLE 205
Cdd:PRK13043 162 FYKGNKPVLTLKELDFRIRQTLIKNKKLYNGEFNKGQIKIT-ADGNNYTIDLSKKLK 217
|
|
| PRK13349 |
PRK13349 |
superantigen-like protein SSL13; Reviewed; |
140-223 |
3.54e-07 |
|
superantigen-like protein SSL13; Reviewed;
Pssm-ID: 106307 Cd Length: 241 Bit Score: 49.29 E-value: 3.54e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 446591657 140 KGKEEPQSSLYQIY---KEDISLKELDYRLRERAIKHHGLYSKGLKQGQITITMNDgTTHTIDLSQKLEKERMGQSVDGK 216
Cdd:PRK13349 150 KDKAETFTGGFPVYegnKPVLTLKELDFRIRQTLIKSKKLYNNSYNKGQIKITGAD-NNYTIDLSKRLPSTDANRYVKKP 228
|
....*..
gi 446591657 217 QIQKILV 223
Cdd:PRK13349 229 QNAKIEV 235
|
|
|